The BTS MDR-TB Clinical Advice Service

New MDR-TB Clinical Advice Service Available from January 2018

BTS has redeveloped and improved its MDR-TB Clinical Advice Service, by which advice and support is given to clinicians who encounter MDR-TB and wish to receive advice about treatment. Support from Public Health England and NHS England is gratefully acknowledged.

The new UK-wide online service is now available.  If you are a clinician who would like to make use of this service for expert advice from a multi-disciplinary panel of formally appointed expert Clinical Service Advisers, please register using the link below.

Click here to access the new MDR-TB Clinical Advice Service website

The BTS MDR-TB Clinical Advice Service has received Ethics Committee approval (26th October 2017. Ref: 17/LO/1539).



Previous MDR-TB Clinical Advice Service

The previous MDR-TB Service was a resource for clinicians treating patients who have MDR-TB, providing robust clinical advice on a case by case basis.

As the new BTS MDR-TB Clinical Advice Service is now available, the previous BTS MDR-TB Service is no longer open to new cases. Cases already registered on the previous BTS MDR-TB Service may continue to be discussed on that platform until the end of March 2018. From April 2018 onwards the previous BTS MDR-TB Service will no longer be available and data will not be retained. 

Click here to access the previous MDR-TB Service website.

For more information please contact


BTS Clinical Statement: the Management of Multidrug-Resistant Tuberculosis
Advice on the 2016 WHO guidance for the management of MDRTB in the context of the UK is now available in the November 2016 BTS Clinical Statement.
14 December 2016